ADEC Solutions and Zuellig Pharma to partner in Pharma KPO joint venture

8 August 2011

Philippines-based ADEC Solutions , an end-to-end business process outsourcing (BPO) global market provider of customized outsourcing solutions, announced a partnership agreement with Malaysia’s Zuellig Pharma, to create a global pharmaceutical and health care-focused knowledge process outsourcing (KPO) and BPO company.

The new joint venture, operating under a 50/50 ownership agreement, will operate under the name Pharma KPO. The JV, which will be incorporated in Singapore, is forged on ADEC Solutions and Zuellig Pharma's commitment on proactively anticipating and adapting to industry trends to facilitate operational changes by streamlining costly and repetitive back office and support processes to enable clients to refocus on strategic activities.

Pharma KPO expects to capitalize on innovative synergies, enhanced by the shared knowledge expertise and efficiency that both parent companies are already known for in their respective space. It aims to take advantage of cost-driven business opportunities by providing processes to fill the demand for alternative service delivery models, with an immediate focus on information technology, BPO, KPO, shared services, and general administrative and support functions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical